Replies to post #1773 on Spotlight Innovation Inc. (fka STLT)

[Work Harder]

Great success

works for me :}

https://www.popsci.com/science/article/2011-11/snake-venom-fights-advanced-cancer-new-clinical-trial

[Work Harder]

The company maintains its own colony of breeding rattlesnakes in the US.

https://www.irishtimes.com/business/health-pharma/celtic-biotech-to-start-snake-venom-cancer-drug-trials-1.632990

[Work Harder]

This is CB24

The therapeutic response obtained in some patients is quite promising and deserves additional development of this compound under a Phase II clinical trial. The recommended dose for Phase II studies is 0.18 mg/m2.

http://clincancerres.aacrjournals.org/content/8/4/1033.full